Literature DB >> 2647235

Parasitism in llamas.

J M Cheney1, G T Allen.   

Abstract

Llamas in North America are infected with a number of helminth parasites, including: gastrointestinal nematodes, lungworms, meningeal worms, tapeworms, and flukes. Most of these helminths can be treated with the anthelmintic currently used to treat cattle and sheep. At least two protozoan parasites, coccidia and toxoplasma, have been reported in the llamas in North America. Coccidia can be controlled with the anticoccidial drugs used to control these organisms in other domestic animals. Toxoplasma has been reported uncommonly in llamas in North America and control is very difficult. Several external parasites occur in llamas in North America, including lice, mites, ticks, and the deer nasal bot. Except for the deer nasal bot, the other external parasites in the llama can be treated with pesticides approved for use in cattle.

Entities:  

Mesh:

Year:  1989        PMID: 2647235     DOI: 10.1016/s0749-0720(15)31011-2

Source DB:  PubMed          Journal:  Vet Clin North Am Food Anim Pract        ISSN: 0749-0720            Impact factor:   3.357


  3 in total

1.  Toxoplasma gondii and Neospora caninum seroprevalences in domestic South American camelids of the Peruvian Andes.

Authors:  Amanda Chávez-Velásquez; Adriana Aguado-Martínez; Luis M Ortega-Mora; Eva Casas-Astos; Enrique Serrano-Martínez; Gina Casas-Velásquez; Jose A Ruiz-Santa-Quiteria; Gema Alvarez-García
Journal:  Trop Anim Health Prod       Date:  2014-05-25       Impact factor: 1.559

2.  Toxoplasma gondii and Neospora caninum infections in South American camelids in Switzerland and assessment of serological tests for diagnosis.

Authors:  Walter Basso; Elena Sollberger; Gereon Schares; Susanne Küker; Flurin Ardüser; Gaia Moore-Jones; Patrik Zanolari
Journal:  Parasit Vectors       Date:  2020-05-14       Impact factor: 3.876

3.  Neonatal diseases in llamas and alpacas.

Authors:  Claire E Whitehead
Journal:  Vet Clin North Am Food Anim Pract       Date:  2009-07       Impact factor: 3.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.